Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And math challenged.
Yeah everyone is hurting longs except the shitty company that hasn't done anything right since it's inception, not to mention it's peddling a product that doesn't work. And building CDMOs from those hurting long's wallets so LP can sell them to line her own.
Time is running out. Only another 15 years and zero approvals ever.
Gamblers have much better odds than idiots.
Zero ORR is the future of placebos.
Then provide links dumbass.
Care to link to that information? Or is it impossible to link to your butthole?
Why would Canada care about the UKs drug approval process which has only been around since post 2020 Brexit?
Nobody cares about the MHRA and their decisions influence nobody.
I’ve got 20 million shares at $0.17. Trust me!
The IP of a worthless product is worthless. Advent producing for companies with approved products like they do now is not.
Nobody here really cares about GBM patients. If they did they wouldn’t attack oncologists who actually treat GBM patients who have commented negatively on the trainwreck P3.
Big news like they need to resubmit but not. In Crayon like the last submission?
Normal people get off a rollercoaster when it has come to a screeching halt.
Longs aren't ever allowed to sell so it's a moot point. Congrats. It's only 33% down from 3 months ago.
Did you dig up your post from 2017 when you probably said the same thing?
It's baffling people don't understand the basics of trading volume.
This has traded 3 million shares on a 1.2 billion OS. Its twice the daily volume which is nothing. Today's increased is simply speculators trading another GBM stock on the NVCR news.
NVCR is trading 10% of it's OS on it's news. 10 million traded on a 107 million OS. THAT'S what trading on news or information looks like. Simple concept.
Astonishing to morons on this board and nowhere else. Everyone else knows how trials are run and efficacy proven.
Flaskworks does nothing right now. Let me know when they run the comparability studies. If it creates a bunch of DCVax, congratulations. You have a bunch of placebo.
BP buys speculative products that have potential all the time. And they have no problem scaling up production unlike NWBO using million dollar reject Flaskworks out of someone else's trashcan.
If it was a slam dunk, then by your misguided idea of how MHRA approval works, shouldn't it have been approved by now?
My bad.
A $250,000 pillow.
Better?
Jama doesn't approve drugs or biologics. You should read the comments from actual oncologists who aren't involved in the trial. Ones that don't claim to own a million shares also.
Hasn't been proven to do shit. If it was, they would've submitted to the FDA when the trial ended and they hit their trial stopping criteria 6 years ago. Then the EU would've approved it and the UK would've piggybacked and approved it.
Instead they are waiting for an MHRA rejection IF their submission was complete but who actually thinks they didn't eff that up just like they did the trial.
I could target hitting a car with a pillow 10 times and be successful 10 times but it does nothing to the car. Just like DCVax.
The difference is this appears to work and DCVax doesn't.
No patient level data for the unmatched control arm won’t pass muster with any RA.
OS with an RCT is the gold standard not changing the trial after failing the first protocol and using unmatched ECA years after the last patient was treated.
If it had “”known positive results” they wouldn’t have changed the endpoints and they would have submitted a BLA to the FDA 3 years ago. Instead they submit the garbage they did to the MHRA with an unmatched ECA because the FDA is explicit about defining the ECA prior to running the trial. The MHRA will reject it for the same reason even though they don’t have that requirement in writing. It’s all to buy time and kick the can down the road while Advent builds its business so LP can sell it while laughing to the bank.
Perhaps she wants something that works.
I guess you haven’t seen the oncologists who are not involved in this scam trial, who have commented on the external control arm being bullshit. Not to mention the FDA requirement of defining the external control arm before you run the trial.
“It also isn’t proven to increase long term survival in GBM patients.”
It would be if they compared it to some bullshit, external control arm.
Yes legitimate companies admit when they did not hit their endpoint and end the trial, not change the endpoints and throw a Hail Mary in the UK.
The company has no combo trials near a P3 and no money to run one.
Or have better odds and go buy a Mega Millions ticket.
100 years from now flipper will still be talking about shipping labels and job openings and the company will still be blaming Covid for never having anything approved.
This biotech will always be pre-revenue while LP has pocketed a few hundred million for an expensive placebo.
You have no idea. LP said numerous times that they had money to get this to the finish line AND advance Direct (to more trials showing it does nothing). This after she fleeced Woodford for $95 million and fleeced shareholders by building 2 CDMOs while they got zero benefit.
If you understood the basics of a shady penny stock you would’ve put your money in an index fund or AAPL and would have actual gains instead of your red paper in your .50 stock.
The post to which you are referring has nothing to do with Direct. True, neither one work, but this is specifically regarding the tiny L trial with very few GBM patients, only 6% (one patient) reaching 60 months. If anything, this just highlights that the P3 uses the least effective treatment which is why they didn't compare it to an actual control arm.
If we are digging up old trials, might as well regurgitate the long term survival of the early ICT-107 trial :
Only one GBM patient in the Poly-ICIC arm lived over 4 years. None of the other 4 lived over 29 months.
The longest living GBM patient between the placebo arm and the Poly-ICIC was in the placebo arm. The only one who lived over 5 years.
So this trial shows the following:
Only one of the 15 GBM patients in this trial lived over 5 years. Therefore the 5 year OS expectancy of a GBM patient receiving DCVax is 1/15 = 6%. About what is expected from SOC.
Thanks UCLA for proving your own treatment doesn't work. See what we can conclude from following breadcrumbs?
Polaroid has a bunch of useless patents too.
Be careful. After they change Cofer’s Depends, he’s coming after you!
Glad that Hoffman and Dr. Blabla paid pumping have been exposed.